IRIS
FOSCHI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.107
AS - Asia 3.059
EU - Europa 2.292
SA - Sud America 835
AF - Africa 107
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.407
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.943
SG - Singapore 1.346
RU - Federazione Russa 725
BR - Brasile 667
IT - Italia 588
CN - Cina 440
VN - Vietnam 435
HK - Hong Kong 433
DE - Germania 189
FR - Francia 182
FI - Finlandia 145
NL - Olanda 112
IN - India 104
GB - Regno Unito 93
CA - Canada 78
MX - Messico 67
AR - Argentina 65
AT - Austria 48
ES - Italia 39
EC - Ecuador 37
ID - Indonesia 36
BD - Bangladesh 35
IQ - Iraq 33
ZA - Sudafrica 33
PL - Polonia 32
JP - Giappone 30
SE - Svezia 30
IE - Irlanda 23
CL - Cile 20
TR - Turchia 19
CO - Colombia 18
ET - Etiopia 16
UZ - Uzbekistan 16
AE - Emirati Arabi Uniti 15
IR - Iran 15
PK - Pakistan 15
SA - Arabia Saudita 14
PY - Paraguay 13
UA - Ucraina 13
MY - Malesia 12
DZ - Algeria 11
LT - Lituania 11
MA - Marocco 10
TH - Thailandia 10
KZ - Kazakistan 9
TN - Tunisia 9
CH - Svizzera 7
VE - Venezuela 7
EG - Egitto 6
IL - Israele 6
RO - Romania 6
AU - Australia 5
BE - Belgio 5
CZ - Repubblica Ceca 5
HU - Ungheria 5
NP - Nepal 5
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
KR - Corea 4
PE - Perù 4
PH - Filippine 4
RS - Serbia 4
SY - Repubblica araba siriana 4
AL - Albania 3
AO - Angola 3
CG - Congo 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
KE - Kenya 3
PS - Palestinian Territory 3
TW - Taiwan 3
AF - Afghanistan, Repubblica islamica di 2
BO - Bolivia 2
DK - Danimarca 2
GA - Gabon 2
GD - Grenada 2
JM - Giamaica 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
NG - Nigeria 2
PT - Portogallo 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
BB - Barbados 1
BJ - Benin 1
BY - Bielorussia 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
Totale 11.393
Salva come PNG Salva come JPEG
Città #
Dallas 2.299
Singapore 751
San Jose 659
Hong Kong 424
Ashburn 362
Santa Clara 245
Boardman 158
Ho Chi Minh City 142
Council Bluffs 135
The Dalles 128
Moscow 123
Lauterbourg 113
Hanoi 106
New York 98
Los Angeles 88
Lappeenranta 83
Hefei 78
Beijing 70
São Paulo 65
Munich 52
Orem 43
Milan 42
Frankfurt am Main 38
Mexico City 37
Verona 35
Helsinki 34
Montreal 34
Rome 33
Warsaw 28
Da Nang 27
L’Aquila 27
Rio de Janeiro 26
Turku 25
Stockholm 23
Shanghai 22
West Jordan 22
Chennai 21
Haiphong 20
Tokyo 20
Curitiba 19
Denver 19
London 19
Benevento 18
Dublin 18
Düsseldorf 18
Amsterdam 17
Brooklyn 17
Guayaquil 17
Nuremberg 17
Atlanta 15
Bologna 15
Johannesburg 15
Poplar 15
Tashkent 15
Toronto 15
Ankara 14
Mumbai 14
Turin 14
Boston 13
Vienna 13
Brasília 12
Phoenix 12
Chicago 11
City of London 11
Kitzingen 11
Manchester 11
Spoltore 11
St Louis 11
Chandler 10
Falkenstein 10
Ha Long 10
Jakarta 10
Taizhou 10
Baghdad 9
Belo Horizonte 9
Campinas 9
Charlotte 9
Florence 9
Hải Dương 9
Madrid 9
New Delhi 9
Salvador 9
Santiago 9
Assago 8
Houston 8
Ribeirão Preto 8
Thái Bình 8
Biên Hòa 7
Changsha 7
Columbus 7
Jinan 7
Naples 7
Palermo 7
Pescara 7
Piscataway 7
Porto Alegre 7
Quito 7
Addis Ababa 6
Bogotá 6
Bắc Ninh 6
Totale 7.423
Salva come PNG Salva come JPEG
Nome #
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study 347
Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis 333
Coronary Artery Disease and Atherosclerosis in Other Vascular Districts: Epidemiology, Risk Factors and Atherosclerotic Plaque Features 292
Implementing Blood Biomarkers in Stroke Research and Clinical Practice 288
Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years 275
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 270
High-Density Lipoprotein Cholesterol Levels and their impact on outcomes in acute ischemic stroke patients treated with mechanical thrombectomy 209
Persistent progression independent of relapse activity in multiple sclerosis 190
Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage 162
Age‐Specific Differences in Inflammatory Biomarkers and Their Impact on Futile Recanalization After Mechanical Thrombectomy: An Inverse Probability Weighting Analysis 162
Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 155
C-Reactive Protein elevation and subsequent atrial fibrillation detection after ischemic stroke treated with mechanical thrombectomy: an inverse probability weighting analysis 150
Point-Of-Care low-field MRI in acute Stroke (POCS): protocol for a multicentric prospective open-label study evaluating diagnostic accuracy 149
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 143
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 141
Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 132
Changing life expectancy in European countries 1990-2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021 128
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 120
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis 117
Real‐World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study 115
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 107
Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis 102
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 99
Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke 98
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 98
Sex-based differences in inflammatory predictors of outcomes in patients undergoing mechanical thrombectomy: an inverse probability weighting analysis 98
Do antithrombotic drugs have a role in migraine prevention? A systematic review 96
A REAl-life study on short-term Dual Antiplatelet treatment in Patients with ischemic stroke or Transient ischemic attack (READAPT) 96
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 94
Outcomes of Mechanical Thrombectomy in Patients With Ischemic Stroke and Heart Failure. A Systematic Review and Meta‐analysis 93
Epidemiology and treatment of atraumatic subarachnoid hemorrhage over 10 years in a population-based registry 92
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: a propensity matched analysis 90
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 88
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 85
Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study 85
Acute stroke-like deficits associated with nonketotic hyperglycemic hyperosmolar state: an illustrative case and systematic review of literature 81
Sex Differences in the Epidemiology of Intracerebral Hemorrhage Over 10 Years in a Population‐Based Stroke Registry 81
Oral anticoagulation versus no anticoagulation for stroke prevention in patients with intracranial haemorrhage and atrial fibrillation: an updated meta-analysis of randomised controlled trials 79
Global burden of vision impairment due to age-related macular degeneration, 1990–2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021 79
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 77
Incidence and prognosis of first-ever intracerebral hemorrhage on antiplatelet therapy over 10 years in a population-based stroke registry 77
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study 77
State of health and inequalities among Italian regions from 2000 to 2021: a systematic analysis based on the Global Burden of Disease Study 2021 76
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 76
The Italian Multiple Sclerosis Register Experience With Cladribine 75
Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack 75
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 74
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries 74
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 72
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort study 71
Impact of Sex on Clinical Outcomes of Tandem Occlusion in Acute Ischemic Stroke Patients Treated With Mechanical Thrombectomy. A Propensity‐Matched Analysis 71
Antithrombotic treatment of cervical arterial dissection: Big data needed to inform long-term management 71
The impact of inflammatory markers on clinical outcomes in acute ischemic stroke patients following mechanical thrombectomy: A multicentre study 71
How far are we from bringing intensive care bundle for intracerebral hemorrhage into the real-world setting? A 5-year population based-study 70
Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing-remitting multiple sclerosis 70
Switch from fingolimod to ozanimod for safety or intolerance reasons 70
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities 70
Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine 69
Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 69
Identifying Cladribine prescription pattern in MS: an Italian multicentre study 67
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024) 66
Sleep-related disorders and their relationship with MRI findings in multiple sclerosis 66
Predictors of futile recanalization after intravenous thrombolysis in stroke patients transferred for endovascular treatment 65
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis 65
Capsular Warning Syndrome: Features, Risk Profile, and Prognosis in a Large Prospective TIA Cohort 63
Frequency and characteristics of dysautonomic symptoms in multiple sclerosis: a cross-sectional double-center study with the validated Italian version of the Composite Autonomic Symptom Score-31 63
Risk of stroke with different levels of leisure-time physical activity: a systematic review and meta-analysis of prospective cohort studies 63
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging: Results from the READAPT study 62
Predictors of atrial fibrillation detection in embolic stroke of undetermined source patients with implantable loop recorder 62
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study 61
Outcomes of different anesthesia techniques in nonagenarians treated with mechanical thrombectomy for anterior circulation large vessel occlusion: An inverse probability weighting analysis 61
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 60
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis 60
Safety and Outcomes of Mechanical Thrombectomy in Acute Ischemic Stroke Attributable to Cardiological Diseases: A Scoping Review 59
Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020 59
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 57
Enhancing stroke risk prediction in patients with transient ischemic attack: insights from a prospective cohort study implementing fast-track care 57
Annual level changes of serum neuronal and glial biomarkers in a German professional football club 57
Epidemiology and outcomes of intracerebral hemorrhage associated with oral anticoagulation over 10 years in a population-based stroke registry 56
“NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab” 55
Stress hyperglycemia is associated with futile recanalization in patients with anterior large vessel occlusion undergoing mechanical thrombectomy 54
Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023 54
A call for academic pragmatic clinical trials to address open questions in migraine prevention 54
Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis 54
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis 54
Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease 53
Impact of Atrial Fibrillation on Outcomes in Stroke Patients with Tandem Occlusions Treated with Thrombectomy.A multicentre study 53
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 52
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 52
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable 51
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 51
Clinicoradiological Profile and Functional Outcome of Acute Cerebral Venous Thrombosis: A Hospital-Based Cohort Study 51
Blood GFAP as an emerging biomarker in brain and spinal cord disorders 51
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis 49
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 49
Pregnancy-Related Disease Outcomes in Women With Moderate to Severe Multiple Sclerosis Disability 49
Another Nail in the Coffin of Causality for the Diastolic Blood Pressure J Curve 49
Neurofilament light chain and glial fibrillary acidic protein as diagnostic and prognostic biomarkers in epileptic seizures and epilepsy: A systematic review 49
Outcomes of mechanical thrombectomy in acute stroke patients with atrial fibrillation detected after stroke versus known atrial fibrillation 47
Migraine with aura, thrombophilia, and the debate on white matter hyperintensities 47
Totale 9.381
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.642
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211 0 0 0 0 0 0 0 0 0 7 1 3
2022/202390 1 2 0 3 3 4 0 2 12 1 5 57
2023/2024391 6 10 16 47 22 47 3 3 3 85 63 86
2024/20252.742 106 28 195 99 229 178 292 205 629 259 264 258
2025/20268.364 277 2.307 793 1.073 564 341 1.066 464 754 725 0 0
Totale 11.598